Walleye Capital’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$163K 6160
2024
Q1
$163K Sell
500
-200
-29% -$49.1K ﹤0.01% 4104
2023
Q4
$133K Sell
700
-2,300
-77% -$435K ﹤0.01% 3911
2023
Q3
$597K Buy
3,000
+1,200
+67% +$284K ﹤0.01% 2670
2023
Q2
$514K Sell
1,800
-900
-33% -$250K ﹤0.01% 2421
2023
Q1
$585K Buy
+2,700
New +$526K 0.01% 1584
2022
Q4
Sell
-800
Closed -$222K 3748
2022
Q3
$222K Buy
+800
New +$203K ﹤0.01% 2041

Other funds holding SWAV

Walleye Capital's SWAV Position: Q4 2023 in Review

Walleye Capital sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q4 2023, closing a stake of 45,211 shares — an estimated $8.54M sold.

Walleye Capital first reported a position in SWAV in Q4 2020 and held it in 7 quarters. The position peaked at $9M in Q3 2023. 427 funds tracked by Wall St. Rank hold SWAV as of Q4 2023.

  • Walleye Capital reported no remaining Shockwave Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Walleye Capital sold 45,211 Shockwave Medical, Inc. Common Stock shares in Q4 2023, an estimated $8.54M.
  • Walleye Capital first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2020 and held it in 7 quarters.
  • Walleye Capital's Shockwave Medical, Inc. Common Stock position peaked at $9M in Q3 2023.
  • 427 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q4 2023.

Based on Walleye Capital's 13F filing for Q4 2023, filed 14 Feb 2024.